Skip to main content
Premium Trial:

Request an Annual Quote

Sygnis Signs Distribution Deal with BioCat for DNA Amplification Kit

NEW YORK (GenomeWeb) – Sample prep firm Sygnis today announced a non-exclusive deal with BioCat to distribute the True Prime Single Cell WGA kit for DNA amplification, Sygnis' first proprietary product.

The True Prime Single Cell WGA kit uses a novel multiple displacement amplification method to amplify total genomic DNA of single cells for next-generation sequencing. It will be the first in a series of TruePrime products for DNA or RNA amplification and is expected to be launched in January 2015, the firm said in a statement.

The agreement grants BioCat non-exclusive rights to promote, market, sell, and support the kit. Financial and other details of the deal were not disclosed.

"The superior features of TruePrime make it highly attractive for use in areas such as human genetics, oncology, or pathology, where researchers need to obtain biological information from the smallest amounts of samples," BioCat CEO Michael Ehret said in a statement. "This agreement will provide us with a product to more effectively address the fast growing market of next-generation sequencing."

With offices in Heidelberg, Germany and Madrid, Spain, Sygnis specializes in the development and commercialization of products for DNA amplification and sequencing.